Key physiological differences in Candida albicans CDRI induction by steroid hormones and antifungal drugs

Yeast

Volumn 23, Issue 11, 2006, Pages 795-802

  Larsen, Bryan ^a   Anderson, Seth ^a   Brockman, Andrea ^a   Essmann, Michael ^a   Schmidt, Martin ^a  

^a Des Moines University College of Osteopathic Medicine   (United States)

Author keywords

Candida; CDRI; GFP; Oestrogen; Progesterone

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; ESTRADIOL; ESTROGEN; FLUCONAZOLE; FLUOROURACIL; GREEN FLUORESCENT PROTEIN; MICONAZOLE; OXYGEN; PROGESTERONE; STEROID HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDR1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; FLOW CYTOMETRY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SEX DIFFERENCE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; ESTRADIOL; FEMALE; FLOW CYTOMETRY; FUNGAL PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; PROGESTERONE;

CANDIDA; CANDIDA ALBICANS; MAMMALIA;

EID: 33748927323     PISSN: 0749503X     EISSN: 10970061     Source Type: Journal    
DOI: 10.1002/yea.1394     Document Type: Article

References (25)

1. Alarco AM, Raymond M. 1999. The bZIP transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J Bacteriol 181(3): 700-708.
2. Albertson GD, Niimi M, Cannon RD, Jenkinson HF. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 40: 2835-2841.
3. Beers MH, Berkow R. 2006. The Merck Manual. Merck Research Laboratories: Whitehouse Station, NJ.
4. Burke D, Dawson D, Stearns T. 2000. Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
5. Burt ET, Daly R, Hoganson D, Tsirulnikov Y, Essmann M, Larsen B. 2003. The isolation and partial characterization of HSP90 from Candida albicans. Ann Clin Lab Sci 33: 86-93.
6. Burt ET, O'Connor C, Larsen B. 1999. Isolation and identification of a 92 kDa stress-induced protein from Candida albicans. Mycopathologia 147: 13-20.
7. Cheng G, Yeater KM, Hoyer L. 2006. Cellular and molecular biology of Candida albicans estrogen response. Eukar Cell 5: 180-191.
8. Coste AT, Kararaba M, Ischer F, Bille J, Sanglard D. 2004. TAC1, transcriptional activator of CDR1 genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukar Cell 3: 1639-1652.
9. Coste AT, Turner V, Ischer F, et al. 2006. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172: 2139-2156.
10. Daniels W, Glover DD, Essmann M, Larsen B. 2001. Candidiasis during pregnancy may result from isogenic commensal strains. Infect Dis Obst Gynecol 9: 1-9.
11. de Micheli M, Bille J, Schueller C, Sanglard D. 2002. A common drug responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43: 1197-1214.
12. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 194: 717-728.
13. Gerami-Nejad M, Berman J, Gale C. 2001. Cassettes for PCR-mediated construction of green, yellow and cyan fluorescent protein fusions in Candida albicans. Yeast 18: 859-864.
14. Glover DD, Larsen B. 2003. Relationship of fungal vaginitis therapy to prior antibiotic exposure. Infect Dis Obst Gynecol 11: 157-160.
15. Gujjar P, Finucane M, Larsen B. 1997. The effect of estradiol on Candida albicans growth. Ann Clin Lab Sci 27: 151-156.
16. Karnani N, Gaur NA, Jha S, et al. 2004. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter. Yeast 3: 219-239.
17. Krishnamurthy S, Gupta V, Snehlata P, Prasad R. 1998a. Characterization of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette superfamily. FEMS Microbiol Lett 158: 69-74.
18. Krishnamurthy S, Gupta V, Prasad R, Panwar SL, Prasad R. 1998b. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol Lett 160: 191-197.
19. O'Connor C, Essmann M, Larsen B. 1998. 17-β estradiol upregulates the stress response in Candida albicans: implications for microbial virulence. Infect Dis Obstet Gynecol 6: 176-181.
20. Pina-Vaz C, Rodrigues AG, Costa-de-Oliveira S, Ricardo E, Mardh PA. 2005. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 56: 678-685.
21. Puri N, Krishnamurthy S, Habib S, et al. 1999. CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. FEMS Microbiol Lett 180: 213-219.
22. Sheehan DJ, Hitchcock CA, Sibley CM. 1999. Current and emerging azole antifungal agents. Clin Micro Rev. 12: 40-79.
23. Tarry W, Fisher M, Shen S, Mawhinney M. 2005. Candida albicans: the estrogen target for vaginal colonization. J Surg Res 192: 278-282.
24. White S, Larsen B. 1997. Candida albicans morphogenesis is influenced by oestrogen. Cell Mol Life Sci 53: 744-749.
25. Zhang XQ, Essmann M, Burt E, Larsen B. 2000. Oestrogen effects on Candida albicans: a potential virulence-regulating mechanism. J Infect Dis 181: 1441-1446.